Lyon

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Childhood cancers1 trial
• Colorectal cancer1 trial
• COPD1 trial
• Endometrial cancer1 trial
• Hepatitis B1 trial
• HIV1 trial
• Prostate cancer1 trial
• Sarcoma1 trial

Phase

• Phase 1/23 trials
• Phase 32 trials
• Phase 21 trial

Status

• Recruiting3 trials
• Active, not recruiting2 trials
• Completed1 trial

Lead sponsor

• GlaxoSmithKline5 trials
• ViiV Healthcare1 trial

Running trials

• Recruiting

  A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)

  NCT07602777· Phase 1/2· GlaxoSmithKline· Source

  Contact: Armelle Dufresne (principal investigator)

• Recruiting

  A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

  NCT07213609· Phase 1/2· GlaxoSmithKline· Source

  Contact: Isabelle Ray Coquard (principal investigator)

• Recruiting

  A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer

  NCT06990880· Phase 1/2· GlaxoSmithKline· Source

  Contact: Armelle Vinceneux (principal investigator)

• Active, not recruiting

  A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)

  NCT06537414· Phase 2· GlaxoSmithKline· Source

• Active, not recruiting

  Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants

  NCT02938520· Phase 3· ViiV Healthcare· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers1 recruiting
• Colorectal cancer1 recruiting
• Endometrial cancer1 recruiting
• Prostate cancer1 recruiting
• Sarcoma1 recruiting

Closed trials

• Completed

  Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level

  NCT04133909· Phase 3· GlaxoSmithKline· Source